Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	5,281	5,159	5,073	3,706	9,456	4,003
Revenue Growth	2.95%	1.68%	36.90%	-60.81%	136.22%	12.58%
Gross Profit Gross Profit Growth	630.9	614.5	545.13	365.92	7,645	392.15
Operating Income Operating Income Growth	-22,284	-22,323	-21,998	-20,511	-16,308	-47,101
Net Income Net Income Growth	-286,634	-192,587	-33,799	-17,224	-11,136	-47,370
Earnings Per Share EPS Growth	-3456.66	-2343.80	-439.20	-240.20	-168.00	-773.60
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Complex Distribution Complex Distribution Growth	3,710	1,905	4,006	3,555	2,871
Bio Bio Growth	-	7,552	-	-	76.51

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	122,092	82,091	802.87	27,433	58,263	39,013
Total Debt Total Debt Growth	64,992	79,561	17,240	6,476	7,074	7,233
Net Cash (Debt) Net Cash Growth	57,100	2,530	-16,437	20,957	51,189	31,781
Net Cash Growth	226.81%	-	-	-59.06%	61.07%	-22.18%
Net Cash Per Share Net Cash Per Share Growth	688.59	30.79	-213.60	292.25	772.24	519.01

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-11,298	-24,014	-20,452	-24,109	-26,776	-40,020
Capital Expenditures CapEx Growth	-1,213	-1,196	-129.26	-260.58	-68.52	-548.04
Free Cash Flow Free Cash Flow Growth	-12,510	-25,210	-20,581	-24,370	-26,844	-40,568
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	11.95%	11.91%	10.75%	9.87%	80.85%	9.80%
Operating Margin	-421.96%	-432.73%	-433.58%	-553.45%	-172.46%	-1176.59%
Pretax Margin	-5427.31%	-3732.85%	-668.07%	-457.93%	-103.86%	-1177.86%
Profit Margin	-5427.70%	-3733.25%	-666.19%	-464.76%	-117.77%	-1183.31%
FCF Margin	-236.90%	-488.69%	-405.66%	-657.56%	-283.88%	-1013.40%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	315.68	1284.12	364.17	176.95	64.77	129.55

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error